7,345 Shares in Hims & Hers Health, Inc. $HIMS Purchased by W.G. Shaheen & Associates DBA Whitney & Co

W.G. Shaheen & Associates DBA Whitney & Co acquired a new position in shares of Hims & Hers Health, Inc. (NYSE:HIMS) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 7,345 shares of the company’s stock, valued at approximately $366,000.

Several other institutional investors also recently added to or reduced their stakes in the business. Smartleaf Asset Management LLC increased its position in Hims & Hers Health by 15.7% in the 1st quarter. Smartleaf Asset Management LLC now owns 1,672 shares of the company’s stock worth $49,000 after buying an additional 227 shares during the period. Bessemer Group Inc. increased its position in Hims & Hers Health by 105.8% in the 2nd quarter. Bessemer Group Inc. now owns 607 shares of the company’s stock worth $30,000 after buying an additional 312 shares during the period. True Vision MN LLC increased its position in Hims & Hers Health by 3.6% in the 2nd quarter. True Vision MN LLC now owns 9,376 shares of the company’s stock worth $467,000 after buying an additional 328 shares during the period. Allworth Financial LP increased its position in Hims & Hers Health by 20.0% in the 1st quarter. Allworth Financial LP now owns 2,006 shares of the company’s stock worth $56,000 after buying an additional 334 shares during the period. Finally, Signaturefd LLC increased its position in Hims & Hers Health by 17.7% in the 1st quarter. Signaturefd LLC now owns 2,586 shares of the company’s stock worth $76,000 after buying an additional 388 shares during the period. 63.52% of the stock is owned by institutional investors.

Insider Activity at Hims & Hers Health

In related news, CFO Oluyemi Okupe sold 11,592 shares of the business’s stock in a transaction on Friday, October 17th. The stock was sold at an average price of $57.13, for a total value of $662,250.96. Following the sale, the chief financial officer owned 70,232 shares of the company’s stock, valued at $4,012,354.16. The trade was a 14.17% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Michael Chi sold 900 shares of the business’s stock in a transaction on Friday, October 10th. The shares were sold at an average price of $58.25, for a total value of $52,425.00. Following the completion of the sale, the insider directly owned 291,439 shares in the company, valued at approximately $16,976,321.75. This represents a 0.31% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 1,432,271 shares of company stock valued at $74,229,585 in the last 90 days. 17.71% of the stock is owned by corporate insiders.

Analyst Ratings Changes

Several research analysts have commented on HIMS shares. Needham & Company LLC reaffirmed a “hold” rating on shares of Hims & Hers Health in a research report on Tuesday, August 5th. Wall Street Zen downgraded Hims & Hers Health from a “buy” rating to a “hold” rating in a research report on Monday, July 28th. Zacks Research cut Hims & Hers Health from a “strong-buy” rating to a “hold” rating in a report on Tuesday, August 19th. KeyCorp began coverage on Hims & Hers Health in a report on Tuesday, October 21st. They issued a “sector weight” rating for the company. Finally, Canaccord Genuity Group reaffirmed a “buy” rating and issued a $68.00 price target on shares of Hims & Hers Health in a report on Friday, September 12th. Two equities research analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat, the company has an average rating of “Reduce” and a consensus target price of $38.92.

Hims & Hers Health Trading Up 3.4%

Shares of HIMS opened at $45.55 on Monday. The stock has a 50 day simple moving average of $51.39 and a 200-day simple moving average of $50.61. The company has a current ratio of 4.98, a quick ratio of 4.46 and a debt-to-equity ratio of 1.72. The stock has a market cap of $10.30 billion, a PE ratio of 56.94, a PEG ratio of 3.15 and a beta of 2.20. Hims & Hers Health, Inc. has a 1 year low of $18.33 and a 1 year high of $72.98.

Hims & Hers Health (NYSE:HIMS) last announced its quarterly earnings results on Monday, August 4th. The company reported $0.17 EPS for the quarter, missing the consensus estimate of $0.18 by ($0.01). The company had revenue of $544.83 million during the quarter, compared to analyst estimates of $550.06 million. Hims & Hers Health had a net margin of 9.63% and a return on equity of 26.26%. Hims & Hers Health’s quarterly revenue was up 72.6% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.06 EPS. On average, sell-side analysts predict that Hims & Hers Health, Inc. will post 0.29 EPS for the current fiscal year.

Hims & Hers Health Profile

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.